Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06160752
Title Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations (SURF201)
Acronym SURF201
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Tyra Biosciences, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Francisco (UCSF) RECRUITING San Francisco California 94143 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
The Ohio State University RECRUITING Columbus Ohio 43210 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field